Cellectar Biosciences, Inc. Share Agreements
1 Contracts & Agreements
- NOVELOSTHERAPEUTICS, INC. WARRANTTO PURCHASE 9,230,769 SHARES OF COMMONSTOCK, PAR VALUE $0.00001 PER SHARE (Filed With SEC on February 18, 2009)